JENNIFER MAGNESS: Open Payments
NPI 1437403938 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$896 in 51 payments from 13 companies in 2025. Trend: 2023 $1,102 · 2024 $599 · 2025 $896
Food & beverage: $896
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $203 |
| Averitas Pharma Inc. | 12 | $157 |
| Collegium Pharmaceutical, Inc. | 5 | $102 |
| ABBVIE INC. | 4 | $82 |
| Boston Scientific Corporation | 2 | $66 |
| Valinor Pharma, LLC | 6 | $55 |
| Medtronic, Inc. | 3 | $50 |
| Forte Bio-Pharma LLC | 2 | $47 |
| Saluda Medical Americas, Inc. | 2 | $46 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $29 |
Products named: RELISTOR, QUTENZA, Belbuca, MOVANTIK, INCEPTIV, PROLATE, Evoke, BOTOX.
Industry payments across OK — which companies pay providers there.
